Una (HP), March 29 -- The operating hours for bars, clubs, pubs, liquor enclosures, and restaurants in the Una district have been revised through an amendment to previously issued orders. Una Distric... Read More
Afghanistan, March 29 -- Thousands of Americans rallied nationwide on Saturday, denouncing Donald Trump's policies, expanding presidential power, immigration crackdowns and the war with Iran. Thousan... Read More
New Delhi, March 29 -- Foreign investors have pulled out Rs.1.14 lakh crore (about $12.3 billion) from domestic equities in March, making it the worst monthly outflow, weighed down by escalating tensi... Read More
India, March 29 -- President Donald Trump recently revealed a pet name he uses for Kimberly Guilfoyle, the ex-fiancee of Donald Trump Jr. and current ambassador to Greece. The nickname has drawn criti... Read More
New Delhi, March 29 -- Kolkata Knight Riders (KKR) assistant coach Shane Watson said that the three-time IPL champions are waiting for an update on pacer Matheesha Pathirana, who has been recovering f... Read More
India, March 29 -- Aditya Dhar's Dhurandhar film 'lore' continues as the internet is shocked to learn that an actor from the film began his career with a Daler Mehndi song. Actor Bimal Oberoi, who pla... Read More
Singapore, March 29 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemother... Read More
Singapore, March 29 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safe... Read More
Singapore, March 29 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) ... Read More
Singapore, March 29 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig ... Read More